Burn injury or other trauma
condition, including surgery can lead to a scar. Several factors impact the
appearance and treatment of scar after an injury. Topical Scar Treatment, Laser
Treatment, and Invasive Surgical Treatment are some of the options for scar
tenement.
China
Scar Treatment Market is estimated to account for US$ 2,422.5 Mn in terms
of value by the end of 2019.
China Scar Treatment Market:
Drivers
Increasing aesthetic appeal among
the populace in China is expected to boost growth of China scar treatment
market. Moreover, increasing product launch and assessment is also expected to
boost growth of the market over the forecast period. For instance, in June
2019, AVITA Medical, a regenerative medicine company, announced new preliminary
RECELL Autologous Cell Harvesting Device (RECELL System) data at the 24th
annual World Congress of Dermatology Meeting. The RECELL system is used in the
treatment of vitiligo and facial acne scars.
China Scar Treatment Market:
Opportunities
Increasing R&D in skin defect
reconstruction is expected to offer lucrative growth opportunities for market
players over the forecast period. For instance, in August 2019, researchers
from Naval Medical University, China, reported that use of minced
split-thickness skin grafts with Pelnac as an overlay can be effective in
reconstruction of full-thickness skin defects.
China Scar Treatment Market:
Restraints
Stringent regulations in China
are expected to hamper growth of the market. China has complicated and
stringent regulatory requirements. It requires over 18 months to gain market
access in the country.
Key Takeaways:
The Aesthetic Lasers segment in
the China scar treatment market was valued at US$ 1,119.8 Mn in 2018 and is
expected to reach US$ 2,717.3 Mn by 2027 at a CAGR of 10.4% during the forecast
period. The growth of the segment is attributed to increasing number of
aesthetic surgical procedures in the country
The laser treatment segment held
dominant position in China scar treatment market in 2018, accounting for 45%
share in terms of volume, followed by topical treatment and invasive surgical
treatment, respectively. The growth of the segment is attributed to increasing
demand for non-invasive surgical procedures.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3154
Market Trends
The demand for over-the-counter
cosmetic laser and light devices has increased in the recent past. These home
use devices use various technologies such as intense pulsed light (IPL) and
light-emitting diodes (LED).
Cosmetic or plastic surgery and
other scar treatment and related products are available at a very affordable
price in China. This can be attributed to high competitiveness among market
players.
Regulations
The market is regulated by
China’s Good Manufacturing Practices and FDA.
Manufacturer needs to establish a
quality management system as China’s FDA guidelines to maintain product
consistency and quality throughout
Manufacturer are required to
strictly implement GMP with integrity without any falsification
Measurability of quality,
consistency and efficacy needs to be well documented to ensure
pharmacovigilance
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/china-scar-treatment-market-3154
Sampling, manufacturing, and
development of drugs should only be carried out by trained personnel
Location, design, layout,
construction, adaption and maintenance of premises should suit the drug
production requirements and minimize risk of contamination
China Scar Treatment Market:
Competitive Landscape
Major players operating in China
scar treatment market include, Cynosure, Inc., Syneron Medical Ltd., Mölnlycke
Health Care, Ostar Beauty Sci-Tech Co., Ltd., Shanghai Fosun Pharmaceutical Co.
Ltd., Beijing Toplaser Technology Co., Ltd., Merz Pharma, and Luca Pharmaceuticals.
Key Developments
Key players in the market are
focused on adopting inorganic growth strategies to expand their product
portfolio. For instance, in November 2019, AVITA Medical collaborated with the
Gates Center for Regenerative Medicine at the University Of Colorado School Of
Medicine to establish proof-of-concept and explore further development of a
spray-on treatment of genetically modified cells for patients with
epidermolysis bullosa (EB) and other genetic skin disorders.
In December 2019, Janssen
Biotech, Inc. entered a definitive agreement to acquire all rights to the
investigational compound bermekimab – an anti-IL-1alpha monoclonal antibody for
the treatment of atopic dermatitis and hidradenitis suppurativa— from XBiotech
Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3154
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment